Let's Combinate - Drugs + Devices with Subhi Saadeh

Let's Combinate - Drugs + Devices with Subhi Saadeh

By Subhi SaadehScienceLife Sciences
Download on the App Store

Let's Combinate - Drugs + Devices with Subhi Saadeh episodes

  • 103 - Prescription Reconciliation, Medication Error Reduction, Automated Home Care, Assisted Robotics, Patient Behavioral Monitoring, and the future of Clinical Trials with Charles Gellman
    On this episode, I was joined by Charles Gellman, CEO of HiDO.
    - How to know people are actually taking their medications
    - Eliminating Medication Errors in the Home
    - Medication Reconciliation, Drug Libraries and Dealing with Contraindications
    - Clinical Trial Monitoring in the Future
    - Chaining Technology and Re-Training Behavioral Change
    Charles Gellman is the CEO & Co-Founder of HiDO Health. NIH funded research in collaboration with Stanford and Rush Universities. He is one of the top voices on AI assisted robotics, digital health and the impact on care. Charles Gellman was recently featured in a full feature documentary, "AI Robotics... The HiDO Story." He publishes his analyses regularly in the newsletter, "The Future of Care." He is a former advisor for StartXMed and has worked in various executive roles at Startups as well as Fortune 500 companies. He received an MSHI degree from University of California at Davis, Medical School.
    HiDO Documentary Trailerhttps://www.youtube.com/watch?v=ljnFImTNpwg
    30 min
  • 102 - Human Error, Doing Quality Differently, Defining Accountability, Written Human Guidance, Blue Line vs. Black Line and Categorizing Deviations with Amy Wilson and Cliff Berry

    On this episode, I was joined by ⁠Amy Wilson and Cliff Berry, authors of "Do Quality Differently: The Playbook for Creating More Success in Biopharma (or Any) Manufacturing".


    Amy and Cliff walkthrough:

    • Human Performance and Challenges
    • Defining Accountability from a Quality World-View
    • Good Written Human Guidance
    • Automating Procedure and QMS Feedback
    • Categorizing Deviations Appropriately
    • Blue Line vs. Black Line: Work as Imagined vs. Work as Completed

    • Amy Wilson: Amy has more than 20 years of biopharma manufacturing experience, focusing on human & organizational performance, operational excellence, risk management and technical training. She has led a global integration of Human & Organizational Performance within biopharma manufacturing. Amy has a Ph.D. in Industrial Engineering from North Carolina State University.

      Cliff Berry: Cliff has worked in the domain of Human & Organizational Performance for over 20 years. He has experience in commercial nuclear electric generation, electric transmission & distribution, gas distribution, nuclear plant systems controls hardware & software integration, and most recently in biopharma manufacturing since 2015 where his primary focus is on creating more quality success. Cliff has a M.S. in Occupational Ergonomics & Safety from the University of Massachusetts Lowell.

      33 min
    • 101 - Micro-Array Patches, Combination Products in Australia, Differences between TGA and RoW, Novel Delivery Systems, and Clinical Trials with Megan Polidano

      On this episode, I was joined by Megan Polidano, Head of Clinical and Regulatory affairs at Vaxxas.

      Megan walks through:

      • Micro-Array Patches and Needle Free Injections
      • EPAR's and AusPAR's
      • Combination Products in Australia
      • Clinical Trials in Australia
      • Australia Regulatory Pathways - Core A and Core B
      • Megan Polidano is the Head of Clinical and Regulatory affairs at Vaxxas. Megan has worked in regulatory affairs since 2007 and have worked for large pharmaceutical and medical device companies as well as small biotechnology companies in Australia and in the US.

        30 min
      • 100 - PQMCoach, Our First Recording, Quality (Big Q/little q), Why Predictive Quality Management, and Communicating Quality with Larry Mager

        On this episode, I was joined by one of my favorite guests, Larry Mager of Mgmt-Ctrl and PQMCoach.com. Larry walks through:

        • Episode 100 and the first recording with Larry!
        • Quality - Big Q/little q
        • Building a QMS and Commercializing a product at a startup
        • Predictive Quality Management, PDCA and TOC
        • Lessons from Pharma, Combination Products, and CRO Companies
        • Communicating quality
        • Larry is the Principal and Founder at Mgmt-Ctrl, a company that focuses on bringing thoughtful quality management that goes beyond compliance only. He has three decades of experience in the medical device industry, and has held responsible positions within medical device manufacturing companies ranging from start-ups to multisite, highly matrixed organizations. He has held executive management responsibilities in both quality management and operations management roles and is experienced in interrelated quality disciplines, such as quality systems, management control, CAPA, supplier control and management, risk management, quality assurance/control, lean manufacturing, product development engineering, and results-oriented management for continuous improvement. You can reach Larry at [email protected]

          31 min
        • 099 - Medical Device vs. Medicinal Product Reviews in the EU, Working at MHRA, Notified Bodies, EU MDR, ICH Q6 and Writing All About It with Janine Jamieson

          On this episode, I was joined by Janine Jamieson, European Editor at International Pharmaceutical Quality.

          In this episode, Janine walks through:
          -Medical Device vs. Medicinal Product Reviews in the EU
          -Working at MHRA as a Pre-Market Reviewer on Devices with an Ancillary Medicinal Substance
          -Notified Bodies, EU MDR and Article 117
          -European Commission, Member States and European Member States Structure
          -Writing about combination products in the EU
          Janine is European Editor at IPQ (International Pharmaceutical Quality) Publications, living in Sweden and writing about the regulatory dialogue at biopharma conferences. She writes about quality/CMC issues, innovation and reliance, and drug-device combination products.
          Between 1997 and 2016, Janine was a pharmaceutical assessor at the UK MHRA, where she focused on device-drug combination products, working with several EU notified bodies, and with MHRA colleagues on drug-device combination products and borderline classification issues. She helped with training, set up a cross-agency combination product working group, and was involved in horizon scanning and innovation office activities at MHRA and EMA.
          She has also been an enthusiastic contributor to TOPRA, The Organization for Professionals in Regulatory Affairs, from special interest networks to training and chairing conference sessions.


          41 min
        • 098 - MedTech vs. Aerospace Risk Management, AFAP vs. ALARP/ALARA, Quantifying Benefit, Risk Control Measures, and Risk Management Reports with Bijan Elahi

          On this episode I was joined by Bijan Elahi, Award winning Medical Device Risk Management author, educator and consultant.

          Bijan walks through:

          • MedTech vs. Aerospace - Differences in Risk Management Approaches
          • Risk Control/Reduction - AFAP vs. ALARP or ALARA and Global Requirements
          • Quantifying Benefit and Benefit/Risk
          • Risk Control Measures
          • What a good risk management process looks
          • Bijan Elahi has worked in risk management for medical devices for over 29 years at the largest medical device companies in the world, as well as small startups. He is a Technical Fellow, and the Medtronic corporate Advisor on safety risk management of medical devices. In this capacity, he offers education and consulting on risk management to all Medtronic business units, worldwide. Bijan is a lecturer at Eindhoven University of Technology (Netherlands), where he teaches risk management to doctoral students in engineering. At the invitation of the FDA, he is also teaching a graduate course on medical device risk management at Drexel University (Philadelphia, USA).


            Contact: You can contact Bijan at his website: https://www.medtechsafety.com

            41 min
          • 097 - Predictive Quality, Business Process Capabilities, 3 Lines of Quality Defense, TOC, COSO and Business Risk with Larry Mager

            On this episode, I was joined by one of my favorite guests, Larry Mager of Mgmt-Ctrl and PQMCoach.com. Larry walks through:

            • Predictive Quality Management and PDCA
            • Business Process Capabilities and process stewardship
            • 3 Lines of Quality Defense
            • COSO Risk Management
            • Larry is the Principal and Founder at Mgmt-Ctrl, a company that focuses on bringing thoughtful quality management that goes beyond compliance only. He has three decades of experience in the medical device industry, and has held responsible positions within medical device manufacturing companies ranging from start-ups to multisite, highly matrixed organizations. He has held executive management responsibilities in both quality management and operations management roles and is experienced in interrelated quality disciplines, such as quality systems, management control, CAPA, supplier control and management, risk management, quality assurance/control, lean manufacturing, product development engineering, and results-oriented management for continuous improvement. You can reach Larry at [email protected]

              44 min
            • 096 - Pharma Waste Management, Sustainability, What Happens to Sharps, Disposal and Zero Waste with Heather Johnson

              On this episode I was joined by Heather Johnson who's the CEO of Ingenium.


              In this episode, expect to learn:

              • Why Waste Management in Pharma might be more complicated than you might think

              • Different kinds of sharps, why sharps are challenging and what happens to sharps containers?

              • Waste potential and repurposing orphan chemicals

              • And what Zero Waste means for sustainability


              Heather Johnson has over 25 years of expertise in the hazardous waste management industry as a C-level Executive, Sales/Marketing Director and Account Manager. As a seasoned entrepreneur who has launched several existing waste management firms, Heather is a founding partner of INGENIUM and currently serves as its Chief Executive Officer.

              Heather’s innovative vision into sustainability for regulated waste management has positioned INGENIUM as an industry leader in innovative waste to energy programs and has provided INGENIUM’s clients with environmentally friendly alternatives to waste disposal, including zero waste initiatives. Heather is well known for her participation in the industry, including her past presidency of BioNet, a non-profit association devoted to biological safety. She has also served on the Board of Directors for several local non-profit organizations and has made community service a priority for INGENIUM and its employees.

              21 min
            • 095 - How FMEA fits into ISO14971, Probabilities, Severity of Harm, RPN's, pFMEA's and making it simpler with Naveen Agarwal
              On this episode, I was joined again by one of my favorite people in risk management, Naveen Agarwal. In this episode, Naveen discussses:
              - How FMEA's fit into ISO14971
              - pFMEA's from External Partners and linking to risk files
              - Simplifying Risk Management outputs for Audit
              Naveen Agarwal PhD is an Engineer by training with nearly 20 years of professional experience in Product Development, Quality Systems and Data Analytics. As a result, he's developed a very broad and deep expertise in all of the core functions involved in the entire lifecycle of medical products. Naveen joins us from Creative Analytics Solutions where his mission is Helping Medical Companies Build Safe Products. Naveen is a PhD Polymer scientist turned QM consultant and expert.
              Show Notes and Links:
              Let’s Talk Risk Newsletter: https://naveenagarwalphd.substack.com
              Naveen’s Video on “When FDA Disagrees with your risk calculation method”: https://youtu.be/Y14_RTHMGqw
              Warning Letter 1: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medtronic-inc-617539-12092021
              Warning Letter 2: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/irhythm-technologies-inc-643474-05252023
              M
              44 min
            • 094 - Connected Combination Products, Product Traceability, Regulating New Products, Pre-Determined Changes and AI/ML with Rumi Young

              On this episode, I was joined by Rumi Young, Director of Regulatory Policy at Beckton Dickinson(BD).

              Rumi walks through:

              • Connected Devices and Combination Products
              • How Regulators approach regulating new technologies
              • Traceability Technologies and what they mean for manufacturing and use
              • Comparability Protocols and Pre-Determined Change Controls for Drugs and Devices
              • Rumi Young, Meng, RAC is the Director of Regulatory Policy at Becton Dickinson (BD). In this role she leads a team that advances policies to speed time to market, promote innovation and ensure reasonable regulatory requirements for medical devices, diagnostics and combination products. Rumi joined BD from FDA where she spent four years in CDRH’s Division of Drug Delivery, General Hospital and Human Factors. As Acting Assistant Director for Injection Devices, her team was responsible for the approval of drug delivery injection devices and combination products such as syringes, auto injectors, pen injectors, on-body injectors and smart connected devices. Prior to FDA Rumi worked at Genentech and AstraZeneca for eight years in combination product development. Rumi has both a Bachelors in Chemistry and Chemical Biology and Masters in Engineering in Material Science from Cornell University.

                37 min

              About Let's Combinate - Drugs + Devices with Subhi Saadeh

              From the publisher's feed

              Hello Combi-Nation!

              More shows like Let's Combinate - Drugs + Devices with Subhi Saadeh

              Planet Money by NPR

              Planet Money

              30,703 Listeners

              The Audible with Stew, Bruce & Ralph: A show about college football by The Athletic

              The Audible with Stew, Bruce & Ralph: A show about college football

              1,241 Listeners

              The Daily by The New York Times

              The Daily

              111,868 Listeners

              Up First from NPR by NPR

              Up First from NPR

              56,446 Listeners

              RAQA Today by Michelle Lott

              RAQA Today

              0 Listeners